- Home
- BTCT vs RANI Comparison
BTCT vs RANI Comparison
Compare BTCT & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTCT
- RANI
- Stock Information
- Founded
- BTCT 2006
- RANI 2012
- Country
- BTCT Singapore
- RANI United States
- Employees
- BTCT N/A
- RANI N/A
- Industry
- BTCT Other Consumer Services
- RANI Medicinal Chemicals and Botanical Products
- Sector
- BTCT Real Estate
- RANI Health Care
- Exchange
- BTCT Nasdaq
- RANI Nasdaq
- Market Cap
- BTCT 19.8M
- RANI 19.6M
- IPO Year
- BTCT N/A
- RANI 2021
- Fundamental
- Price
- BTCT $2.98
- RANI $0.56
- Analyst Decision
- BTCT
- RANI Strong Buy
- Analyst Count
- BTCT 0
- RANI 4
- Target Price
- BTCT N/A
- RANI $7.75
- AVG Volume (30 Days)
- BTCT 132.3K
- RANI 287.9K
- Earning Date
- BTCT 08-13-2025
- RANI 08-05-2025
- Dividend Yield
- BTCT N/A
- RANI N/A
- EPS Growth
- BTCT N/A
- RANI N/A
- EPS
- BTCT N/A
- RANI N/A
- Revenue
- BTCT $11,675,000.00
- RANI $1,200,000.00
- Revenue This Year
- BTCT $13.58
- RANI N/A
- Revenue Next Year
- BTCT N/A
- RANI N/A
- P/E Ratio
- BTCT N/A
- RANI N/A
- Revenue Growth
- BTCT 28.68
- RANI N/A
- 52 Week Low
- BTCT $1.32
- RANI $0.46
- 52 Week High
- BTCT $26.58
- RANI $4.19
- Technical
- Relative Strength Index (RSI)
- BTCT 42.20
- RANI 35.97
- Support Level
- BTCT $2.75
- RANI $0.51
- Resistance Level
- BTCT $3.25
- RANI $0.56
- Average True Range (ATR)
- BTCT 0.21
- RANI 0.03
- MACD
- BTCT 0.00
- RANI 0.01
- Stochastic Oscillator
- BTCT 47.30
- RANI 21.50
About BTCT BTC Digital Ltd.
BTC Digital Ltd is a crypto asset technology company based in the U.S. with a focus on bitcoin mining. The company also generates revenue through mining machine resale and rental business operations. Geographically, the financial assets of the company is located in the United States, Singapore, Hong Kong and the PRC.
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.